COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 71 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 25 | -19.4% | 0.00% | – |
| Q3 2022 | $3,000 | -98.5% | 31 | -99.8% | 0.00% | -100.0% |
| Q3 2018 | $195,000 | -25.0% | 13,250 | +21.6% | 0.01% | -27.3% |
| Q2 2018 | $260,000 | +89.8% | 10,900 | +47.3% | 0.01% | +83.3% |
| Q1 2018 | $137,000 | 0.0% | 7,400 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $137,000 | +75.6% | 7,400 | 0.0% | 0.01% | +100.0% |
| Q3 2017 | $78,000 | -2.5% | 7,400 | +15.6% | 0.00% | 0.0% |
| Q2 2017 | $80,000 | +25.0% | 6,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $64,000 | -34.0% | 6,400 | +3.2% | 0.00% | -40.0% |
| Q4 2016 | $97,000 | -16.4% | 6,200 | +3.3% | 0.01% | -16.7% |
| Q3 2016 | $116,000 | +75.8% | 6,000 | +7.1% | 0.01% | +50.0% |
| Q2 2016 | $66,000 | – | 5,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |